Amanat Acquisition Corp AMAN
Set alert
10.13 USD +0.03 +0.30%
As of Nov 2, 9:35 AM ET
10.10 Day range 10.10
9.98 52-week range 10.79
- YTD
- +1.20%
- 1 year
- +1.20%
- Open
- 10.10
- Prev close
- 10.10
- Mkt cap
- 97.72M
- Vol
- 5.36K
- Avg vol
- 39.05K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 10.10
- High
- 10.10
6M chart
Signals (12)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 16, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 7, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Oct 2, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| RSI: Overbought | Aug 28, 2026 | 2 months ago |
| RSI: Overbought | Aug 18, 2026 | 2 months ago |
| RSI: Overbought | Aug 3, 2026 | 3 months ago |
| RSI: Overbought | Jul 30, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 27, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 15, 2026 | 3 months ago |
Financials — quick view
AMAN Revenue — quarterly 0
AMAN Net income — quarterly 31.73K
AMAN EPS — quarterly 0.01
News
- Amanat Acquisition To Merge With Corxel Pharmaceuticals; Transaction Includes Concurrent, Oversubscribed PIPE With Expected Gross Proceeds Of ~$300M In Addition To ~$75M In Amanat’s Trust Account
- Corxel US and Amanat Acquisition Corp Announce Definitive Business Combination Agreement to Create Publicly Listed Obesity-Focused Biopharmaceutical Company
- Amanat Acquisition Corp. (NASDAQ:AMAN) Shares Shorted: Short Interest Down 50.6% in September
Your note
Sign in to keep a note on AMAN — it syncs with the Stock Master app.